Beam Therapeutics Inc (BEAM)
24.73
+0.94
(+3.95%)
USD |
NASDAQ |
May 17, 16:00
24.73
0.00 (0.00%)
After-Hours: 20:00
Beam Therapeutics Cash and Short Term Investments (Quarterly): 1.095B for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.095B |
December 31, 2023 | 1.190B |
September 30, 2023 | 1.015B |
June 30, 2023 | 1.073B |
March 31, 2023 | 1.059B |
December 31, 2022 | 1.078B |
September 30, 2022 | 1.095B |
June 30, 2022 | 1.166B |
March 31, 2022 | 1.223B |
December 31, 2021 | 965.65M |
September 30, 2021 | 933.40M |
Date | Value |
---|---|
June 30, 2021 | 615.28M |
March 31, 2021 | 503.48M |
December 31, 2020 | 299.67M |
September 30, 2020 | 202.22M |
June 30, 2020 | 227.95M |
March 31, 2020 | 253.44M |
December 31, 2019 | 91.85M |
September 30, 2019 | 110.89M |
June 30, 2019 | 126.76M |
December 31, 2018 | 146.44M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
91.85M
Minimum
Dec 2019
1.223B
Maximum
Mar 2022
716.22M
Average
949.53M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Eli Lilly and Co | 2.586B |
Perspective Therapeutics Inc | 180.65M |
Electromed Inc | 11.71M |
Xtant Medical Holdings Inc | 4.547M |
Asensus Surgical Inc | 7.989M |